Skip to main content

WuXi PharmaTech Taps NextCode's Software for Sequence Analysis

Premium

NEW YORK (GenomeWeb) – WuXi PharmaTech, an R&D capability and technology platform provider, said this week that Chinese researchers who use sequencing services provided by the firm's Genome Center will have access to NextCode Health's sequence analysis solutions.

According to WuXi, NextCode will work with the WuXi Genome Center to process its customers''s sequencing data and to generate reports that will describe the medical implications of the findings.

Financial and other terms of the agreement were not disclosed.

Filed under

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.